Ironwood Pharmaceuticals Inc (IRWD)
7.82
-0.26
(-3.22%)
USD |
NASDAQ |
Apr 26, 16:00
7.81
-0.01
(-0.13%)
After-Hours: 20:00
Ironwood Pharmaceuticals Revenue (Quarterly): 117.55M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 117.55M |
| September 30, 2023 | 113.74M |
| June 30, 2023 | 107.38M |
| March 31, 2023 | 104.06M |
| December 31, 2022 | 107.20M |
| September 30, 2022 | 108.64M |
| June 30, 2022 | 97.23M |
| March 31, 2022 | 97.53M |
| December 31, 2021 | 117.13M |
| September 30, 2021 | 103.75M |
| June 30, 2021 | 104.03M |
| March 31, 2021 | 88.84M |
| December 31, 2020 | 116.68M |
| September 30, 2020 | 103.47M |
| June 30, 2020 | 89.43M |
| March 31, 2020 | 79.94M |
| December 31, 2019 | 126.30M |
| September 30, 2019 | 131.17M |
| June 30, 2019 | 102.22M |
| March 31, 2019 | 68.73M |
| December 31, 2018 | 130.69M |
| September 30, 2018 | 65.69M |
| June 30, 2018 | 81.11M |
| March 31, 2018 | 69.16M |
| December 31, 2017 | 94.21M |
| Date | Value |
|---|---|
| September 30, 2017 | 86.82M |
| June 30, 2017 | 65.08M |
| March 31, 2017 | 52.17M |
| December 31, 2016 | 87.46M |
| September 30, 2016 | 66.11M |
| June 30, 2016 | 54.35M |
| March 31, 2016 | 66.04M |
| December 31, 2015 | 53.31M |
| September 30, 2015 | 39.57M |
| June 30, 2015 | 27.74M |
| March 31, 2015 | 28.93M |
| December 31, 2014 | 38.07M |
| September 30, 2014 | 16.92M |
| June 30, 2014 | 6.84M |
| March 31, 2014 | 14.60M |
| December 31, 2013 | 5.031M |
| September 30, 2013 | 4.932M |
| June 30, 2013 | 9.663M |
| March 31, 2013 | 3.255M |
| December 31, 2012 | 26.98M |
| September 30, 2012 | 96.41M |
| June 30, 2012 | 14.60M |
| March 31, 2012 | 12.25M |
| December 31, 2011 | 32.15M |
| September 30, 2011 | 12.22M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
79.94M
Minimum
Mar 2020
131.17M
Maximum
Sep 2019
106.12M
Average
104.06M
Median
Mar 2023
Revenue (Quarterly) Benchmarks
| Societal CDMO Inc (DELISTED) | 27.72M |
| OPKO Health Inc | 181.90M |
| Inari Medical Inc | 132.09M |
| Kineta Inc | -- |
| Moderna Inc | 2.813B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.087M |
| Total Expenses (Quarterly) | 74.34M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 1.830B |
| Profit Margin (Quarterly) | -0.92% |
| Earnings Yield | -83.25% |
| Operating Earnings Yield | 12.57% |
| Normalized Earnings Yield | -10.88 |